![Matthew Onaitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Onaitis
Director Financiero/CFO en
MAINSTAY MEDICAL INTERNATIONAL
.
Perfil
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc. He serves as Chief Financial Officer at Mainstay Medical International Ltd. since 2018 and at Mainstay Medical Holdings Plc.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc from 2004 to 2005, Associate General Counsel at Biogen, Inc. in 2006, Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. from 2010 to 2013, Secretary & General Counsel at Trius Therapeutics, Inc. in 2013, Secretary & General Counsel at Ignyta, Inc. from 2014 to 2016, and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. in 2018.
Education includes an undergraduate degree from Carnegie Mellon University in 1993 and a graduate degree from Stanford Law School in 1998.
Cargos activos de Matthew Onaitis
| Empresas | Cargo | Inicio |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Director Financiero/CFO | 20/08/2018 |
Snp Bio, Inc. | Director/Miembro de la Junta | - |
Stratify Genomics, Inc.
 Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Director/Miembro de la Junta | - |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Director Financiero/CFO | - |
Antiguos cargos conocidos de Matthew Onaitis.
| Empresas | Cargo | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Director Financiero/CFO | 17/08/2018 |
| IGNYTA INC | Consejero General | 01/06/2016 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Consejero General | 01/12/2013 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Consejero General | 01/03/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2006 |
Formación de Matthew Onaitis.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
77
Relaciones de 1er grado
12
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Operates as a medical device company, which is engaged in the development of neurostimulation therapies for the population of people with debilitating chronic low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Bolsa de valores
- Insiders
- Matthew Onaitis
